Walleye Trading’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-800
Closed -$44 4829
2017
Q1
$44 Buy
+800
New +$44.1K ﹤0.01% 3834
2016
Q4
Sell
-200
Closed -$10K 5057
2016
Q3
$10K Buy
200
+100
+100% +$5.06K ﹤0.01% 4414
2016
Q2
$6K Sell
100
-312
-76% -$17.2K ﹤0.01% 4964
2016
Q1
$22K Sell
412
-91
-18% -$4.48K ﹤0.01% 4391
2015
Q4
$26K Buy
503
+203
+68% +$10.1K ﹤0.01% 4280
2015
Q3
$14K Sell
300
-100
-25% -$4.72K ﹤0.01% 4251
2015
Q2
$18K Buy
+400
New +$17.5K ﹤0.01% 4038

Other funds holding PBH

Walleye Trading's PBH Position: Q2 2017 in Review

Walleye Trading sold out of Prestige Consumer Healthcare (PBH) in Q2 2017, closing a stake of 800 shares — an estimated $44 sold.

Walleye Trading first reported a position in PBH in Q2 2015 and held it in 7 quarters. The position peaked at $26K in Q4 2015. 232 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • Walleye Trading reported no remaining Prestige Consumer Healthcare position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 800 Prestige Consumer Healthcare shares in Q2 2017, an estimated $44.
  • Walleye Trading first reported a position in Prestige Consumer Healthcare in Q2 2015 and held it in 7 quarters.
  • Walleye Trading's Prestige Consumer Healthcare position peaked at $26K in Q4 2015.
  • 232 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.